Form 10Q Clearpoint Neuro Inc For: 12 August
- Investing.com
- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Clearpoint Neuro Inc (CLPT)
Clearpoint Neuro Inc stock price live, this page displays NASDAQ CLPT stock exchange data. View the CLPT premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Clearpoint Neuro Inc real time stock price chart below.
What Is the Clearpoint Neuro Inc Stock Price Today?
The Clearpoint Neuro Inc stock price today is 10.49.
What Is the Stock Symbol for Clearpoint Neuro Inc?
The stock symbol for Clearpoint Neuro Inc is ""CLPT.""
What Stock Exchange Does Clearpoint Neuro Inc Trade On?
Clearpoint Neuro Inc is listed and trades on the NASDAQ stock exchange.
Is Clearpoint Neuro Inc a Good Stock to Buy?
Determining whether Clearpoint Neuro Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CLPT quote. (ISIN: US18507C1036)
What Is the Clearpoint Neuro Inc Stock Price Today?
The Clearpoint Neuro Inc stock price today is 10.49.
What Is the Stock Symbol for Clearpoint Neuro Inc?
The stock symbol for Clearpoint Neuro Inc is ""CLPT.""
What Stock Exchange Does Clearpoint Neuro Inc Trade On?
Clearpoint Neuro Inc is listed and trades on the NASDAQ stock exchange.
Is Clearpoint Neuro Inc a Good Stock to Buy?
Determining whether Clearpoint Neuro Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CLPT quote. (ISIN: US18507C1036)
NASDAQ
Currency in USD
Fair Value
An estimate of a Clearpoint Neuro's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
10.31
10.57
52 wk Range
9.76
19.22
CLPT Scorecard
Full Analysis
2 analysts have revised their earnings downwards for the upcoming period
CLPT is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a Clearpoint Neuro's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
10.3110.57
52 wk Range
9.7619.22
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
CLPT Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Clearpoint Neuro's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
29.00
Upside
+176.45%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Analysts do not anticipate the company will be profitable this year
- ClearPoint Neuro director sells $132,800 in stock
- Investing.com
- Form 10Q Clearpoint Neuro Inc For: 12 August
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Clearpoint Neuro Inc Company Profile
ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V.; UCB Biopharma SRL; NE Scientific, LLC; and University of California, San Francisco, and Johns Hopkins University. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.
Clearpoint Neuro Inc Earnings Call Summary for Q2/2025
- Q2 2025 EPS of -$0.21 missed forecast of -$0.2; revenue of $9.2M slightly below expected $9.23M
- 17% YoY revenue growth; gross margin decreased to 60% from 63% in 2024
- Launched ClearPoint 3.0 Navigation Software; preparing for commercial launch of new cell and gene therapies
- Operating expenses increased 16% to $11.2M, impacting profitability
- CEO optimistic about approval of additional cell and gene therapy platforms within 2-3 years
Last Updated: 12/08/2025, 22:34
Read Full TranscriptCompare CLPT to Peers and Sector
Metrics to compare | CLPT | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCLPTPeersSector | |
|---|---|---|---|---|
P/E Ratio | −13.4x | −3.9x | −0.6x | |
PEG Ratio | 0.99 | −0.21 | 0.00 | |
Price/Book | 15.1x | 3.6x | 2.6x | |
Price / LTM Sales | 8.9x | 2.4x | 3.3x | |
Upside (Analyst Target) | 176.5% | 36.4% | 39.1% | |
Fair Value Upside | Unlock | 2.7% | 5.4% | Unlock |
Analyst Ratings
2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 29.00
(+176.45% Upside)
Earnings
Latest Release
Aug 12, 2025
EPS / Forecast
-0.21 / -0.20
Revenue / Forecast
9.20M / 9.23M
People Also Watch
FAQ
What Stock Exchange Does Clearpoint Neuro Trade On?
Clearpoint Neuro is listed and trades on the Nasdaq Stock Exchange stock exchange.
What Is the Stock Symbol for Clearpoint Neuro?
The stock symbol for Clearpoint Neuro is "CLPT."
What Is the Clearpoint Neuro Market Cap?
As of today, Clearpoint Neuro market cap is 297.03M.
What Is Clearpoint Neuro's Earnings Per Share (TTM)?
The Clearpoint Neuro EPS (TTM) is -0.80.
When Is the Next Clearpoint Neuro Earnings Date?
Clearpoint Neuro will release its next earnings report on 10 Nov 2025.
From a Technical Analysis Perspective, Is CLPT a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Clearpoint Neuro Stock Split?
Clearpoint Neuro has split 1 times.
How Many Employees Does Clearpoint Neuro Have?
Clearpoint Neuro has 115 employees.
What is the current trading status of Clearpoint Neuro (CLPT)?
As of 29 Aug 2025, Clearpoint Neuro (CLPT) is trading at a price of 10.49, with a previous close of 10.49. The stock has fluctuated within a day range of 10.31 to 10.57, while its 52-week range spans from 9.76 to 19.22.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.